Gaithersburg, MD, United States of America

Panacos Pharmaceuticals, Inc.

Calculating rank
USPTO Granted Patents = 4

% Expired Patents = 75.0


Forward Citations = 29

Loading Chart...
Loading Chart...

8 inventors (with patents filed for the assignee):

goldMedal Carl Thomas Wild (4 out of 19 patents)

silverMedal Graham P Allaway (3 out of 21 patents)

bronzeMedal Eric O Freed (1 out of 3 patents)

4.  Feng Li (1 out of 3 patents)

5.  Kuo-Hsiung Lee (1 out of 56 patents)

6.  Karl Salzwedel (1 out of 2 patents)

7.  Yoshiki Kashiwada (1 out of 6 patents)

8.  Carol D Weiss (1 out of 1 patent)

9.  Robert E Kilkuskie (3 patents)

10.  Mark Manak (5 patents)

11.  Mark Cosentino (4 patents)

12.  Louis Mark Cosentino (3 patents)

13.  Jing-Xi Xie (1 patent)

14.  Kuo-Hsiung Lee (0 patent)

15.  Lan Xie (0 patent)


4 patents:

Company Overview
Panacos Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to developing innovative antiviral therapeutics for the treatment of HIV/AIDS. The company's lead product candidate, bevirimat, is a novel HIV maturation inhibitor that holds promise as a potential new treatment option for individuals living with HIV. Panacos is committed to advancing the field of antiviral drug development and improving patient outcomes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

4 Patents

#87 in Gaithersburg, MD

#897 in Maryland

#60,737 in US

Gaithersburg, MD (US)
Gaithersburg, MD, United States of America
Forward Citations = 29

8 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Panacos Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/panacos-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…